The CTSI, in partnership with the Clinical Research Office, creates and shares educational content, holds instructional sessions, and connects investigators and research teams with useful resources.

Acute Kidney Injury Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight DelveInsight's 'Acute Kidney Injury Pipeline ...

To keep research teams informed of the latest updates to ClinicalTrials.gov, the University at Buffalo Clinical and Translational Science Institute (CTSI) will be providing news about the ...

Parkinson's Disease Clinical Trial Pipeline Boom as 150+ Companies are in the Race for Better Treatments | DelveInsight DelveInsight's 'Parkinson's Disease Pipeline Insight 2026' report provides ...

Improved clinical relevance: Pragmatic trials focus on outcomes that are directly relevant to patients, health care providers, and communities, such as overall survival and health-related quality of ...

Older patients represent the fastest growing patient group in clinical care. They are a heterogeneous group, for whom evidence for making treatment decisions is often scarce. Important domains for ...

Two innovative, forward-thinking organizations show how rebuilding patient trust is becoming the real breakthrough driving faster, more effective clinical trials.

Felicione is an independent clinical research scientist and principal investigator. Walk into any drugstore, natural market, or Costco and you’ll find a dazzling array of supplements promising ...

“Our clinicians engage in research now. It’s the usual care of the patient, and we generate research information from it.” —Louis Fiore, VA Boston Healthcare System The workshop session on innovations ...

There are currently dozens of clinical trials examining new ways to treat mantle cell lymphoma (MCL). People can learn about trial recruitment at ClinicalTrials.gov. Research into mantle cell lymphoma ...

Composite endpoints combine multiple individual outcomes into a single measure to improve statistical power, reduce sample size and capture the multifaceted impact of interventions. They are ...

Over time U.S. investments in clinical research have grown substantially, despite the fact that the rate of increase in funding slowed between 2003-2007. Industry was the largest funder of biomedical ...